Compare MYGN & SPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYGN | SPT |
|---|---|---|
| Founded | 1991 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 444.2M | 449.6M |
| IPO Year | 1996 | 2019 |
| Metric | MYGN | SPT |
|---|---|---|
| Price | $4.28 | $7.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 8 |
| Target Price | $7.64 | ★ $11.75 |
| AVG Volume (30 Days) | ★ 1.5M | 1.2M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.11 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $771,400,000.00 | $457,547,000.00 |
| Revenue This Year | $6.86 | $8.86 |
| Revenue Next Year | $5.45 | $8.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 2.33 | ★ 12.72 |
| 52 Week Low | $3.53 | $4.92 |
| 52 Week High | $8.59 | $21.53 |
| Indicator | MYGN | SPT |
|---|---|---|
| Relative Strength Index (RSI) | 48.53 | 56.15 |
| Support Level | $3.53 | $5.94 |
| Resistance Level | $5.30 | $7.45 |
| Average True Range (ATR) | 0.32 | 0.45 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 42.70 | 39.44 |
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions. Geographically, the company operates in Americas, EMEA, and Asia Pacific, of which it derives maximum revenue from Americas.